nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—ulcerative colitis	0.485	1	CbGaD
Carfilzomib—ABCB1—Methylprednisolone—ulcerative colitis	0.0276	0.257	CbGbCtD
Carfilzomib—ABCB1—Betamethasone—ulcerative colitis	0.018	0.167	CbGbCtD
Carfilzomib—ABCB1—Prednisolone—ulcerative colitis	0.0177	0.165	CbGbCtD
Carfilzomib—ABCB1—Hydrocortisone—ulcerative colitis	0.0168	0.157	CbGbCtD
Carfilzomib—ABCB1—Prednisone—ulcerative colitis	0.0167	0.156	CbGbCtD
Carfilzomib—ABCB1—Dexamethasone—ulcerative colitis	0.0105	0.0974	CbGbCtD
Carfilzomib—PSMB10—lymphoid tissue—ulcerative colitis	0.00808	0.117	CbGeAlD
Carfilzomib—PSMB10—digestive system—ulcerative colitis	0.00798	0.116	CbGeAlD
Carfilzomib—PSMB10—liver—ulcerative colitis	0.00594	0.0862	CbGeAlD
Carfilzomib—PSMB5—smooth muscle tissue—ulcerative colitis	0.00575	0.0834	CbGeAlD
Carfilzomib—PSMB1—smooth muscle tissue—ulcerative colitis	0.00503	0.0729	CbGeAlD
Carfilzomib—PSMB2—smooth muscle tissue—ulcerative colitis	0.00491	0.0712	CbGeAlD
Carfilzomib—PSMB1—lymphoid tissue—ulcerative colitis	0.00402	0.0583	CbGeAlD
Carfilzomib—PSMB1—digestive system—ulcerative colitis	0.00397	0.0576	CbGeAlD
Carfilzomib—PSMB2—lymphoid tissue—ulcerative colitis	0.00392	0.0569	CbGeAlD
Carfilzomib—PSMB2—digestive system—ulcerative colitis	0.00387	0.0562	CbGeAlD
Carfilzomib—PSMB8—liver—ulcerative colitis	0.00383	0.0556	CbGeAlD
Carfilzomib—PSMB5—liver—ulcerative colitis	0.00338	0.0491	CbGeAlD
Carfilzomib—PSMB1—liver—ulcerative colitis	0.00296	0.0429	CbGeAlD
Carfilzomib—PSMB2—liver—ulcerative colitis	0.00289	0.0419	CbGeAlD
Carfilzomib—PSMB8—Balsalazide—Olsalazine—ulcerative colitis	0.00145	0.13	CbGdCrCtD
Carfilzomib—Neuritis—Triamcinolone—ulcerative colitis	0.00111	0.00891	CcSEcCtD
Carfilzomib—Neuritis—Methylprednisolone—ulcerative colitis	0.00111	0.00889	CcSEcCtD
Carfilzomib—Hypoaesthesia—Nicotine—ulcerative colitis	0.00111	0.00886	CcSEcCtD
Carfilzomib—Hepatic failure—Azathioprine—ulcerative colitis	0.0011	0.00881	CcSEcCtD
Carfilzomib—Oedema peripheral—Nicotine—ulcerative colitis	0.0011	0.00878	CcSEcCtD
Carfilzomib—Cardiac disorder—Nicotine—ulcerative colitis	0.00103	0.00827	CcSEcCtD
Carfilzomib—Neuritis—Betamethasone—ulcerative colitis	0.00101	0.00809	CcSEcCtD
Carfilzomib—Neuritis—Dexamethasone—ulcerative colitis	0.00101	0.00809	CcSEcCtD
Carfilzomib—Hypokalaemia—Budesonide—ulcerative colitis	0.00101	0.00807	CcSEcCtD
Carfilzomib—Hepatic failure—Mesalazine—ulcerative colitis	0.001	0.00803	CcSEcCtD
Carfilzomib—Renal failure acute—Mesalazine—ulcerative colitis	0.000976	0.00781	CcSEcCtD
Carfilzomib—Lopinavir—ABCB1—ulcerative colitis	0.000973	0.543	CrCbGaD
Carfilzomib—Back pain—Nicotine—ulcerative colitis	0.000938	0.0075	CcSEcCtD
Carfilzomib—Muscle spasms—Nicotine—ulcerative colitis	0.000932	0.00746	CcSEcCtD
Carfilzomib—Anaemia—Mercaptopurine—ulcerative colitis	0.000924	0.0074	CcSEcCtD
Carfilzomib—Leukopenia—Mercaptopurine—ulcerative colitis	0.000895	0.00716	CcSEcCtD
Carfilzomib—Neuritis—Prednisone—ulcerative colitis	0.00088	0.00704	CcSEcCtD
Carfilzomib—Arthralgia—Mercaptopurine—ulcerative colitis	0.000852	0.00681	CcSEcCtD
Carfilzomib—Cough—Nicotine—ulcerative colitis	0.000846	0.00677	CcSEcCtD
Carfilzomib—Blood creatinine increased—Mesalazine—ulcerative colitis	0.000844	0.00676	CcSEcCtD
Carfilzomib—Hypertension—Nicotine—ulcerative colitis	0.000837	0.0067	CcSEcCtD
Carfilzomib—PSMB8—Balsalazide—Sulfasalazine—ulcerative colitis	0.000833	0.0745	CbGdCrCtD
Carfilzomib—Arthralgia—Nicotine—ulcerative colitis	0.000825	0.0066	CcSEcCtD
Carfilzomib—Ritonavir—ABCB1—ulcerative colitis	0.000818	0.457	CrCbGaD
Carfilzomib—Aspartate aminotransferase increased—Mesalazine—ulcerative colitis	0.000812	0.0065	CcSEcCtD
Carfilzomib—Thrombocytopenia—Mercaptopurine—ulcerative colitis	0.000799	0.0064	CcSEcCtD
Carfilzomib—Anorexia—Mercaptopurine—ulcerative colitis	0.000778	0.00623	CcSEcCtD
Carfilzomib—ABCB1—epithelium—ulcerative colitis	0.000778	0.0113	CbGeAlD
Carfilzomib—Pneumonia—Azathioprine—ulcerative colitis	0.000767	0.00614	CcSEcCtD
Carfilzomib—Oedema peripheral—Budesonide—ulcerative colitis	0.000755	0.00604	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Mercaptopurine—ulcerative colitis	0.000744	0.00595	CcSEcCtD
Carfilzomib—Neutropenia—Mesalazine—ulcerative colitis	0.000729	0.00583	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Mesalazine—ulcerative colitis	0.000724	0.00579	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisolone—ulcerative colitis	0.000724	0.00579	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Nicotine—ulcerative colitis	0.000721	0.00577	CcSEcCtD
Carfilzomib—Insomnia—Nicotine—ulcerative colitis	0.000715	0.00573	CcSEcCtD
Carfilzomib—Cardiac disorder—Budesonide—ulcerative colitis	0.000712	0.00569	CcSEcCtD
Carfilzomib—Decreased appetite—Mercaptopurine—ulcerative colitis	0.00071	0.00568	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Hydrocortisone—ulcerative colitis	0.000707	0.00566	CcSEcCtD
Carfilzomib—Dyspnoea—Nicotine—ulcerative colitis	0.000705	0.00564	CcSEcCtD
Carfilzomib—Pneumonia—Mesalazine—ulcerative colitis	0.000699	0.00559	CcSEcCtD
Carfilzomib—Renal failure—Mesalazine—ulcerative colitis	0.000683	0.00546	CcSEcCtD
Carfilzomib—Fatigue—Nicotine—ulcerative colitis	0.000682	0.00546	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Mesalazine—ulcerative colitis	0.000681	0.00545	CcSEcCtD
Carfilzomib—Pain—Nicotine—ulcerative colitis	0.000676	0.00541	CcSEcCtD
Carfilzomib—Constipation—Nicotine—ulcerative colitis	0.000676	0.00541	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Triamcinolone—ulcerative colitis	0.000666	0.00533	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Methylprednisolone—ulcerative colitis	0.000664	0.00531	CcSEcCtD
Carfilzomib—Back pain—Budesonide—ulcerative colitis	0.000646	0.00517	CcSEcCtD
Carfilzomib—Body temperature increased—Mercaptopurine—ulcerative colitis	0.000645	0.00516	CcSEcCtD
Carfilzomib—Muscle spasms—Budesonide—ulcerative colitis	0.000642	0.00514	CcSEcCtD
Carfilzomib—Body temperature increased—Nicotine—ulcerative colitis	0.000625	0.005	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisolone—ulcerative colitis	0.000624	0.00499	CcSEcCtD
Carfilzomib—Anaemia—Budesonide—ulcerative colitis	0.000617	0.00494	CcSEcCtD
Carfilzomib—Oedema peripheral—Mesalazine—ulcerative colitis	0.000614	0.00492	CcSEcCtD
Carfilzomib—Chills—Azathioprine—ulcerative colitis	0.000614	0.00492	CcSEcCtD
Carfilzomib—Cardiac arrest—Hydrocortisone—ulcerative colitis	0.00061	0.00488	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Betamethasone—ulcerative colitis	0.000604	0.00483	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Dexamethasone—ulcerative colitis	0.000604	0.00483	CcSEcCtD
Carfilzomib—ABCB1—lymphoid tissue—ulcerative colitis	0.000599	0.00869	CbGeAlD
Carfilzomib—ABCB1—digestive system—ulcerative colitis	0.000592	0.00858	CbGeAlD
Carfilzomib—PSMB9—Dexamethasone—Budesonide—ulcerative colitis	0.000591	0.0529	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Budesonide—ulcerative colitis	0.000591	0.0529	CbGdCrCtD
Carfilzomib—Hypokalaemia—Hydrocortisone—ulcerative colitis	0.000583	0.00467	CcSEcCtD
Carfilzomib—Cough—Budesonide—ulcerative colitis	0.000582	0.00466	CcSEcCtD
Carfilzomib—Cardiac disorder—Mesalazine—ulcerative colitis	0.000579	0.00463	CcSEcCtD
Carfilzomib—Hypertension—Budesonide—ulcerative colitis	0.000576	0.00461	CcSEcCtD
Carfilzomib—Cardiac arrest—Triamcinolone—ulcerative colitis	0.000574	0.00459	CcSEcCtD
Carfilzomib—Cardiac arrest—Methylprednisolone—ulcerative colitis	0.000573	0.00458	CcSEcCtD
Carfilzomib—Sepsis—Prednisone—ulcerative colitis	0.00057	0.00456	CcSEcCtD
Carfilzomib—Arthralgia—Budesonide—ulcerative colitis	0.000568	0.00455	CcSEcCtD
Carfilzomib—Asthenia—Nicotine—ulcerative colitis	0.000568	0.00454	CcSEcCtD
Carfilzomib—Chills—Mesalazine—ulcerative colitis	0.00056	0.00448	CcSEcCtD
Carfilzomib—Diarrhoea—Mercaptopurine—ulcerative colitis	0.000559	0.00447	CcSEcCtD
Carfilzomib—Anaemia—Azathioprine—ulcerative colitis	0.000551	0.00441	CcSEcCtD
Carfilzomib—Diarrhoea—Nicotine—ulcerative colitis	0.000541	0.00433	CcSEcCtD
Carfilzomib—Infection—Budesonide—ulcerative colitis	0.000541	0.00433	CcSEcCtD
Carfilzomib—Leukopenia—Azathioprine—ulcerative colitis	0.000533	0.00427	CcSEcCtD
Carfilzomib—Cardiac failure congestive—Prednisone—ulcerative colitis	0.000526	0.00421	CcSEcCtD
Carfilzomib—Back pain—Mesalazine—ulcerative colitis	0.000525	0.0042	CcSEcCtD
Carfilzomib—Dizziness—Nicotine—ulcerative colitis	0.000523	0.00419	CcSEcCtD
Carfilzomib—Muscle spasms—Mesalazine—ulcerative colitis	0.000522	0.00418	CcSEcCtD
Carfilzomib—Cardiac arrest—Betamethasone—ulcerative colitis	0.000521	0.00417	CcSEcCtD
Carfilzomib—Cardiac arrest—Dexamethasone—ulcerative colitis	0.000521	0.00417	CcSEcCtD
Carfilzomib—Anorexia—Budesonide—ulcerative colitis	0.000519	0.00416	CcSEcCtD
Carfilzomib—Vomiting—Mercaptopurine—ulcerative colitis	0.000519	0.00415	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Hydrocortisone—ulcerative colitis	0.000515	0.00412	CcSEcCtD
Carfilzomib—Arthralgia—Azathioprine—ulcerative colitis	0.000507	0.00406	CcSEcCtD
Carfilzomib—Vomiting—Nicotine—ulcerative colitis	0.000503	0.00402	CcSEcCtD
Carfilzomib—Anaemia—Mesalazine—ulcerative colitis	0.000502	0.00402	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisolone—ulcerative colitis	0.000499	0.00399	CcSEcCtD
Carfilzomib—Hypokalaemia—Dexamethasone—ulcerative colitis	0.000498	0.00399	CcSEcCtD
Carfilzomib—Hypokalaemia—Betamethasone—ulcerative colitis	0.000498	0.00399	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Budesonide—ulcerative colitis	0.000496	0.00397	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisolone—ulcerative colitis	0.000496	0.00397	CcSEcCtD
Carfilzomib—Headache—Nicotine—ulcerative colitis	0.000496	0.00397	CcSEcCtD
Carfilzomib—Insomnia—Budesonide—ulcerative colitis	0.000493	0.00394	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Hydrocortisone—ulcerative colitis	0.000487	0.0039	CcSEcCtD
Carfilzomib—Leukopenia—Mesalazine—ulcerative colitis	0.000486	0.00389	CcSEcCtD
Carfilzomib—Dyspnoea—Budesonide—ulcerative colitis	0.000486	0.00389	CcSEcCtD
Carfilzomib—Nausea—Mercaptopurine—ulcerative colitis	0.000485	0.00388	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Triamcinolone—ulcerative colitis	0.000485	0.00388	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Hydrocortisone—ulcerative colitis	0.000484	0.00387	CcSEcCtD
Carfilzomib—Infection—Azathioprine—ulcerative colitis	0.000483	0.00387	CcSEcCtD
Carfilzomib—Thrombocytopenia—Azathioprine—ulcerative colitis	0.000476	0.00381	CcSEcCtD
Carfilzomib—Cough—Mesalazine—ulcerative colitis	0.000474	0.00379	CcSEcCtD
Carfilzomib—Decreased appetite—Budesonide—ulcerative colitis	0.000474	0.00379	CcSEcCtD
Carfilzomib—Nausea—Nicotine—ulcerative colitis	0.00047	0.00376	CcSEcCtD
Carfilzomib—Fatigue—Budesonide—ulcerative colitis	0.00047	0.00376	CcSEcCtD
Carfilzomib—Hypertension—Mesalazine—ulcerative colitis	0.000469	0.00375	CcSEcCtD
Carfilzomib—Pain—Budesonide—ulcerative colitis	0.000466	0.00373	CcSEcCtD
Carfilzomib—Constipation—Budesonide—ulcerative colitis	0.000466	0.00373	CcSEcCtD
Carfilzomib—Arthralgia—Mesalazine—ulcerative colitis	0.000462	0.0037	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Triamcinolone—ulcerative colitis	0.000459	0.00367	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Methylprednisolone—ulcerative colitis	0.000457	0.00366	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Triamcinolone—ulcerative colitis	0.000456	0.00365	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Methylprednisolone—ulcerative colitis	0.000455	0.00364	CcSEcCtD
Carfilzomib—Cardiac arrest—Prednisone—ulcerative colitis	0.000453	0.00363	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Azathioprine—ulcerative colitis	0.000443	0.00355	CcSEcCtD
Carfilzomib—ABCB1—liver—ulcerative colitis	0.000441	0.00639	CbGeAlD
Carfilzomib—Infection—Mesalazine—ulcerative colitis	0.00044	0.00352	CcSEcCtD
Carfilzomib—Hypokalaemia—Prednisone—ulcerative colitis	0.000434	0.00347	CcSEcCtD
Carfilzomib—Thrombocytopenia—Mesalazine—ulcerative colitis	0.000434	0.00347	CcSEcCtD
Carfilzomib—Body temperature increased—Budesonide—ulcerative colitis	0.000431	0.00345	CcSEcCtD
Carfilzomib—Hyperglycaemia—Dexamethasone—ulcerative colitis	0.000427	0.00342	CcSEcCtD
Carfilzomib—Hyperglycaemia—Betamethasone—ulcerative colitis	0.000427	0.00342	CcSEcCtD
Carfilzomib—Anorexia—Mesalazine—ulcerative colitis	0.000422	0.00338	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Betamethasone—ulcerative colitis	0.000416	0.00333	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Dexamethasone—ulcerative colitis	0.000416	0.00333	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Betamethasone—ulcerative colitis	0.000414	0.00331	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Dexamethasone—ulcerative colitis	0.000414	0.00331	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Mesalazine—ulcerative colitis	0.000404	0.00323	CcSEcCtD
Carfilzomib—Insomnia—Mesalazine—ulcerative colitis	0.000401	0.00321	CcSEcCtD
Carfilzomib—Dyspnoea—Mesalazine—ulcerative colitis	0.000395	0.00316	CcSEcCtD
Carfilzomib—Asthenia—Budesonide—ulcerative colitis	0.000391	0.00313	CcSEcCtD
Carfilzomib—Cardiac disorder—Methylprednisolone—ulcerative colitis	0.000387	0.00309	CcSEcCtD
Carfilzomib—Neutropenia—Prednisone—ulcerative colitis	0.000385	0.00308	CcSEcCtD
Carfilzomib—Decreased appetite—Mesalazine—ulcerative colitis	0.000385	0.00308	CcSEcCtD
Carfilzomib—Body temperature increased—Azathioprine—ulcerative colitis	0.000384	0.00308	CcSEcCtD
Carfilzomib—Fatigue—Mesalazine—ulcerative colitis	0.000382	0.00306	CcSEcCtD
Carfilzomib—Constipation—Mesalazine—ulcerative colitis	0.000379	0.00303	CcSEcCtD
Carfilzomib—Pain—Mesalazine—ulcerative colitis	0.000379	0.00303	CcSEcCtD
Carfilzomib—Diarrhoea—Budesonide—ulcerative colitis	0.000373	0.00298	CcSEcCtD
Carfilzomib—Hyperglycaemia—Prednisone—ulcerative colitis	0.000372	0.00298	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Prednisone—ulcerative colitis	0.000362	0.0029	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Prednisone—ulcerative colitis	0.00036	0.00288	CcSEcCtD
Carfilzomib—Dizziness—Budesonide—ulcerative colitis	0.00036	0.00288	CcSEcCtD
Carfilzomib—Back pain—Triamcinolone—ulcerative colitis	0.000352	0.00281	CcSEcCtD
Carfilzomib—Body temperature increased—Mesalazine—ulcerative colitis	0.00035	0.0028	CcSEcCtD
Carfilzomib—Vomiting—Budesonide—ulcerative colitis	0.000346	0.00277	CcSEcCtD
Carfilzomib—Headache—Budesonide—ulcerative colitis	0.000341	0.00273	CcSEcCtD
Carfilzomib—Hypertension—Prednisolone—ulcerative colitis	0.000341	0.00273	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Budesonide—ulcerative colitis	0.000334	0.0299	CbGdCrCtD
Carfilzomib—Hypertension—Hydrocortisone—ulcerative colitis	0.000333	0.00267	CcSEcCtD
Carfilzomib—Diarrhoea—Azathioprine—ulcerative colitis	0.000333	0.00266	CcSEcCtD
Carfilzomib—Nausea—Budesonide—ulcerative colitis	0.000324	0.00259	CcSEcCtD
Carfilzomib—Dizziness—Azathioprine—ulcerative colitis	0.000322	0.00257	CcSEcCtD
Carfilzomib—Asthenia—Mesalazine—ulcerative colitis	0.000318	0.00254	CcSEcCtD
Carfilzomib—Cough—Triamcinolone—ulcerative colitis	0.000317	0.00254	CcSEcCtD
Carfilzomib—Hypertension—Triamcinolone—ulcerative colitis	0.000314	0.00251	CcSEcCtD
Carfilzomib—Hypertension—Methylprednisolone—ulcerative colitis	0.000313	0.00251	CcSEcCtD
Carfilzomib—Infection—Hydrocortisone—ulcerative colitis	0.000313	0.0025	CcSEcCtD
Carfilzomib—Vomiting—Azathioprine—ulcerative colitis	0.000309	0.00247	CcSEcCtD
Carfilzomib—Arthralgia—Methylprednisolone—ulcerative colitis	0.000309	0.00247	CcSEcCtD
Carfilzomib—Headache—Azathioprine—ulcerative colitis	0.000305	0.00244	CcSEcCtD
Carfilzomib—Diarrhoea—Mesalazine—ulcerative colitis	0.000303	0.00243	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Hydrocortisone—ulcerative colitis	0.000303	0.0271	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Hydrocortisone—ulcerative colitis	0.000303	0.0271	CbGdCrCtD
Carfilzomib—Anorexia—Hydrocortisone—ulcerative colitis	0.0003	0.0024	CcSEcCtD
Carfilzomib—Infection—Triamcinolone—ulcerative colitis	0.000295	0.00236	CcSEcCtD
Carfilzomib—Infection—Methylprednisolone—ulcerative colitis	0.000294	0.00235	CcSEcCtD
Carfilzomib—Dizziness—Mesalazine—ulcerative colitis	0.000293	0.00234	CcSEcCtD
Carfilzomib—Insomnia—Prednisolone—ulcerative colitis	0.000292	0.00233	CcSEcCtD
Carfilzomib—Nausea—Azathioprine—ulcerative colitis	0.000289	0.00231	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Hydrocortisone—ulcerative colitis	0.000287	0.0023	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Methylprednisolone—ulcerative colitis	0.000286	0.0255	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Methylprednisolone—ulcerative colitis	0.000286	0.0255	CbGdCrCtD
Carfilzomib—Insomnia—Hydrocortisone—ulcerative colitis	0.000285	0.00228	CcSEcCtD
Carfilzomib—Hypertension—Betamethasone—ulcerative colitis	0.000285	0.00228	CcSEcCtD
Carfilzomib—Hypertension—Dexamethasone—ulcerative colitis	0.000285	0.00228	CcSEcCtD
Carfilzomib—Vomiting—Mesalazine—ulcerative colitis	0.000282	0.00225	CcSEcCtD
Carfilzomib—PSMB9—Dexamethasone—Betamethasone—ulcerative colitis	0.000281	0.0251	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Dexamethasone—ulcerative colitis	0.000281	0.0251	CbGdCrCtD
Carfilzomib—Headache—Mesalazine—ulcerative colitis	0.000278	0.00222	CcSEcCtD
Carfilzomib—Pain—Prednisolone—ulcerative colitis	0.000276	0.00221	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Triamcinolone—ulcerative colitis	0.000275	0.0246	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Triamcinolone—ulcerative colitis	0.000275	0.0246	CbGdCrCtD
Carfilzomib—Decreased appetite—Hydrocortisone—ulcerative colitis	0.000274	0.00219	CcSEcCtD
Carfilzomib—Fatigue—Hydrocortisone—ulcerative colitis	0.000272	0.00217	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Triamcinolone—ulcerative colitis	0.00027	0.00216	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Methylprednisolone—ulcerative colitis	0.00027	0.00216	CcSEcCtD
Carfilzomib—Pain—Hydrocortisone—ulcerative colitis	0.000269	0.00216	CcSEcCtD
Carfilzomib—Insomnia—Triamcinolone—ulcerative colitis	0.000268	0.00215	CcSEcCtD
Carfilzomib—Insomnia—Methylprednisolone—ulcerative colitis	0.000268	0.00214	CcSEcCtD
Carfilzomib—Infection—Betamethasone—ulcerative colitis	0.000267	0.00214	CcSEcCtD
Carfilzomib—Infection—Dexamethasone—ulcerative colitis	0.000267	0.00214	CcSEcCtD
Carfilzomib—Anaemia—Prednisone—ulcerative colitis	0.000265	0.00212	CcSEcCtD
Carfilzomib—Dyspnoea—Triamcinolone—ulcerative colitis	0.000264	0.00212	CcSEcCtD
Carfilzomib—Thrombocytopenia—Betamethasone—ulcerative colitis	0.000264	0.00211	CcSEcCtD
Carfilzomib—Thrombocytopenia—Dexamethasone—ulcerative colitis	0.000264	0.00211	CcSEcCtD
Carfilzomib—Nausea—Mesalazine—ulcerative colitis	0.000263	0.00211	CcSEcCtD
Carfilzomib—PSMB9—Betamethasone—Prednisone—ulcerative colitis	0.000261	0.0233	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisone—ulcerative colitis	0.000261	0.0233	CbGdCrCtD
Carfilzomib—Anorexia—Dexamethasone—ulcerative colitis	0.000257	0.00205	CcSEcCtD
Carfilzomib—Anorexia—Betamethasone—ulcerative colitis	0.000257	0.00205	CcSEcCtD
Carfilzomib—Fatigue—Triamcinolone—ulcerative colitis	0.000256	0.00205	CcSEcCtD
Carfilzomib—Fatigue—Methylprednisolone—ulcerative colitis	0.000255	0.00204	CcSEcCtD
Carfilzomib—PSMB8—Diflorasone—Budesonide—ulcerative colitis	0.000255	0.0228	CbGdCrCtD
Carfilzomib—PSMB9—Betamethasone—Prednisolone—ulcerative colitis	0.000254	0.0227	CbGdCrCtD
Carfilzomib—PSMB9—Dexamethasone—Prednisolone—ulcerative colitis	0.000254	0.0227	CbGdCrCtD
Carfilzomib—Pain—Triamcinolone—ulcerative colitis	0.000254	0.00203	CcSEcCtD
Carfilzomib—Body temperature increased—Hydrocortisone—ulcerative colitis	0.000249	0.00199	CcSEcCtD
Carfilzomib—Hypertension—Prednisone—ulcerative colitis	0.000248	0.00198	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Betamethasone—ulcerative colitis	0.000245	0.00196	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Dexamethasone—ulcerative colitis	0.000245	0.00196	CcSEcCtD
Carfilzomib—Arthralgia—Prednisone—ulcerative colitis	0.000245	0.00196	CcSEcCtD
Carfilzomib—Insomnia—Betamethasone—ulcerative colitis	0.000243	0.00195	CcSEcCtD
Carfilzomib—Insomnia—Dexamethasone—ulcerative colitis	0.000243	0.00195	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Hydrocortisone—ulcerative colitis	0.000236	0.0211	CbGdCrCtD
Carfilzomib—Body temperature increased—Triamcinolone—ulcerative colitis	0.000235	0.00188	CcSEcCtD
Carfilzomib—Decreased appetite—Dexamethasone—ulcerative colitis	0.000234	0.00187	CcSEcCtD
Carfilzomib—Decreased appetite—Betamethasone—ulcerative colitis	0.000234	0.00187	CcSEcCtD
Carfilzomib—Infection—Prednisone—ulcerative colitis	0.000233	0.00186	CcSEcCtD
Carfilzomib—Fatigue—Betamethasone—ulcerative colitis	0.000232	0.00186	CcSEcCtD
Carfilzomib—Fatigue—Dexamethasone—ulcerative colitis	0.000232	0.00186	CcSEcCtD
Carfilzomib—Pain—Betamethasone—ulcerative colitis	0.00023	0.00184	CcSEcCtD
Carfilzomib—Pain—Dexamethasone—ulcerative colitis	0.00023	0.00184	CcSEcCtD
Carfilzomib—Asthenia—Hydrocortisone—ulcerative colitis	0.000226	0.00181	CcSEcCtD
Carfilzomib—Anorexia—Prednisone—ulcerative colitis	0.000223	0.00179	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Methylprednisolone—ulcerative colitis	0.000223	0.0199	CbGdCrCtD
Carfilzomib—Diarrhoea—Hydrocortisone—ulcerative colitis	0.000216	0.00172	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Prednisone—ulcerative colitis	0.000214	0.00171	CcSEcCtD
Carfilzomib—Dizziness—Prednisolone—ulcerative colitis	0.000213	0.00171	CcSEcCtD
Carfilzomib—Asthenia—Triamcinolone—ulcerative colitis	0.000213	0.0017	CcSEcCtD
Carfilzomib—Body temperature increased—Dexamethasone—ulcerative colitis	0.000213	0.0017	CcSEcCtD
Carfilzomib—Body temperature increased—Betamethasone—ulcerative colitis	0.000213	0.0017	CcSEcCtD
Carfilzomib—Asthenia—Methylprednisolone—ulcerative colitis	0.000212	0.0017	CcSEcCtD
Carfilzomib—Insomnia—Prednisone—ulcerative colitis	0.000212	0.0017	CcSEcCtD
Carfilzomib—Dizziness—Hydrocortisone—ulcerative colitis	0.000208	0.00167	CcSEcCtD
Carfilzomib—Decreased appetite—Prednisone—ulcerative colitis	0.000204	0.00163	CcSEcCtD
Carfilzomib—Diarrhoea—Methylprednisolone—ulcerative colitis	0.000203	0.00162	CcSEcCtD
Carfilzomib—Fatigue—Prednisone—ulcerative colitis	0.000202	0.00162	CcSEcCtD
Carfilzomib—Headache—Prednisolone—ulcerative colitis	0.000202	0.00162	CcSEcCtD
Carfilzomib—Constipation—Prednisone—ulcerative colitis	0.0002	0.0016	CcSEcCtD
Carfilzomib—Vomiting—Hydrocortisone—ulcerative colitis	0.0002	0.0016	CcSEcCtD
Carfilzomib—PSMB8—Medrysone—Prednisolone—ulcerative colitis	0.000199	0.0178	CbGdCrCtD
Carfilzomib—Headache—Hydrocortisone—ulcerative colitis	0.000197	0.00158	CcSEcCtD
Carfilzomib—Dizziness—Triamcinolone—ulcerative colitis	0.000196	0.00157	CcSEcCtD
Carfilzomib—Dizziness—Methylprednisolone—ulcerative colitis	0.000196	0.00157	CcSEcCtD
Carfilzomib—Asthenia—Betamethasone—ulcerative colitis	0.000193	0.00155	CcSEcCtD
Carfilzomib—Asthenia—Dexamethasone—ulcerative colitis	0.000193	0.00155	CcSEcCtD
Carfilzomib—Nausea—Prednisolone—ulcerative colitis	0.000192	0.00153	CcSEcCtD
Carfilzomib—Vomiting—Triamcinolone—ulcerative colitis	0.000189	0.00151	CcSEcCtD
Carfilzomib—Vomiting—Methylprednisolone—ulcerative colitis	0.000188	0.00151	CcSEcCtD
Carfilzomib—Nausea—Hydrocortisone—ulcerative colitis	0.000187	0.0015	CcSEcCtD
Carfilzomib—Headache—Triamcinolone—ulcerative colitis	0.000186	0.00149	CcSEcCtD
Carfilzomib—Headache—Methylprednisolone—ulcerative colitis	0.000185	0.00148	CcSEcCtD
Carfilzomib—Body temperature increased—Prednisone—ulcerative colitis	0.000185	0.00148	CcSEcCtD
Carfilzomib—Diarrhoea—Betamethasone—ulcerative colitis	0.000184	0.00147	CcSEcCtD
Carfilzomib—Diarrhoea—Dexamethasone—ulcerative colitis	0.000184	0.00147	CcSEcCtD
Carfilzomib—Dizziness—Dexamethasone—ulcerative colitis	0.000178	0.00142	CcSEcCtD
Carfilzomib—Dizziness—Betamethasone—ulcerative colitis	0.000178	0.00142	CcSEcCtD
Carfilzomib—Nausea—Triamcinolone—ulcerative colitis	0.000176	0.00141	CcSEcCtD
Carfilzomib—Nausea—Methylprednisolone—ulcerative colitis	0.000176	0.00141	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Hydrocortisone—ulcerative colitis	0.000171	0.0153	CbGdCrCtD
Carfilzomib—Vomiting—Betamethasone—ulcerative colitis	0.000171	0.00137	CcSEcCtD
Carfilzomib—Vomiting—Dexamethasone—ulcerative colitis	0.000171	0.00137	CcSEcCtD
Carfilzomib—Headache—Betamethasone—ulcerative colitis	0.000169	0.00135	CcSEcCtD
Carfilzomib—Headache—Dexamethasone—ulcerative colitis	0.000169	0.00135	CcSEcCtD
Carfilzomib—Asthenia—Prednisone—ulcerative colitis	0.000168	0.00135	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Methylprednisolone—ulcerative colitis	0.000162	0.0144	CbGdCrCtD
Carfilzomib—Diarrhoea—Prednisone—ulcerative colitis	0.00016	0.00128	CcSEcCtD
Carfilzomib—Nausea—Dexamethasone—ulcerative colitis	0.00016	0.00128	CcSEcCtD
Carfilzomib—Nausea—Betamethasone—ulcerative colitis	0.00016	0.00128	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Dexamethasone—ulcerative colitis	0.000159	0.0142	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Betamethasone—ulcerative colitis	0.000159	0.0142	CbGdCrCtD
Carfilzomib—PSMB8—Fluorometholone—Triamcinolone—ulcerative colitis	0.000155	0.0139	CbGdCrCtD
Carfilzomib—Dizziness—Prednisone—ulcerative colitis	0.000155	0.00124	CcSEcCtD
Carfilzomib—Vomiting—Prednisone—ulcerative colitis	0.000149	0.00119	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisone—ulcerative colitis	0.000147	0.0132	CbGdCrCtD
Carfilzomib—Headache—Prednisone—ulcerative colitis	0.000147	0.00118	CcSEcCtD
Carfilzomib—PSMB8—Fluorometholone—Prednisolone—ulcerative colitis	0.000144	0.0129	CbGdCrCtD
Carfilzomib—Nausea—Prednisone—ulcerative colitis	0.000139	0.00111	CcSEcCtD
Carfilzomib—PSMB8—Betamethasone—Budesonide—ulcerative colitis	0.000137	0.0122	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Budesonide—ulcerative colitis	0.000137	0.0122	CbGdCrCtD
Carfilzomib—PSMB8—Testosterone Propionate—Hydrocortisone—ulcerative colitis	0.000132	0.0118	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Methylprednisolone—ulcerative colitis	0.000123	0.011	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Dexamethasone—ulcerative colitis	0.000121	0.0108	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Betamethasone—ulcerative colitis	0.000121	0.0108	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Triamcinolone—ulcerative colitis	0.000118	0.0106	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Prednisone—ulcerative colitis	0.000112	0.01	CbGdCrCtD
Carfilzomib—PSMB8—Diflorasone—Prednisolone—ulcerative colitis	0.00011	0.0098	CbGdCrCtD
Carfilzomib—PSMB8—Norethindrone—Hydrocortisone—ulcerative colitis	9.87e-05	0.00882	CbGdCrCtD
Carfilzomib—PSMB8—Levonorgestrel—Hydrocortisone—ulcerative colitis	7.85e-05	0.00702	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Hydrocortisone—ulcerative colitis	6.99e-05	0.00625	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Hydrocortisone—ulcerative colitis	6.99e-05	0.00625	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Methylprednisolone—ulcerative colitis	6.6e-05	0.0059	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Methylprednisolone—ulcerative colitis	6.6e-05	0.0059	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Betamethasone—ulcerative colitis	6.49e-05	0.00581	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Dexamethasone—ulcerative colitis	6.49e-05	0.00581	CbGdCrCtD
Carfilzomib—PSMB8—Betamethasone—Triamcinolone—ulcerative colitis	6.34e-05	0.00567	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Triamcinolone—ulcerative colitis	6.34e-05	0.00567	CbGdCrCtD
Carfilzomib—PSMB2—Disease—ADCY5—ulcerative colitis	6.08e-05	0.000303	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—GHRL—ulcerative colitis	6.06e-05	0.000302	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—GHRL—ulcerative colitis	6.06e-05	0.000302	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—GHRL—ulcerative colitis	6.06e-05	0.000302	CbGpPWpGaD
Carfilzomib—PSMB8—Betamethasone—Prednisone—ulcerative colitis	6.02e-05	0.00538	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisone—ulcerative colitis	6.02e-05	0.00538	CbGdCrCtD
Carfilzomib—PSMB8—Disease—ADCY5—ulcerative colitis	6e-05	0.000299	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—GHRL—ulcerative colitis	5.98e-05	0.000298	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC11A1—ulcerative colitis	5.96e-05	0.000297	CbGpPWpGaD
Carfilzomib—PSMB8—Betamethasone—Prednisolone—ulcerative colitis	5.88e-05	0.00525	CbGdCrCtD
Carfilzomib—PSMB8—Dexamethasone—Prednisolone—ulcerative colitis	5.88e-05	0.00525	CbGdCrCtD
Carfilzomib—PSMB5—Signaling Pathways—CALM3—ulcerative colitis	5.87e-05	0.000292	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CALM3—ulcerative colitis	5.87e-05	0.000292	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CALM3—ulcerative colitis	5.87e-05	0.000292	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CALM3—ulcerative colitis	5.79e-05	0.000288	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RIPK2—ulcerative colitis	5.78e-05	0.000288	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RIPK2—ulcerative colitis	5.78e-05	0.000288	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RIPK2—ulcerative colitis	5.78e-05	0.000288	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CRP—ulcerative colitis	5.76e-05	0.000287	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CRP—ulcerative colitis	5.76e-05	0.000287	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CRP—ulcerative colitis	5.76e-05	0.000287	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RIPK2—ulcerative colitis	5.7e-05	0.000284	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CRP—ulcerative colitis	5.68e-05	0.000283	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ADCY5—ulcerative colitis	5.62e-05	0.00028	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ADCY5—ulcerative colitis	5.59e-05	0.000278	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—NFKB1—ulcerative colitis	5.53e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—NFKB1—ulcerative colitis	5.53e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—NFKB1—ulcerative colitis	5.53e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—TLR4—ulcerative colitis	5.53e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—TLR4—ulcerative colitis	5.53e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—TLR4—ulcerative colitis	5.53e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—HLA-DRB1—ulcerative colitis	5.52e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—HLA-DRB1—ulcerative colitis	5.52e-05	0.000275	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—HLA-DRB1—ulcerative colitis	5.52e-05	0.000275	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CHP1—ulcerative colitis	5.5e-05	0.000274	CbGpPWpGaD
Carfilzomib—PSMB10—Cell Cycle—TP53—ulcerative colitis	5.46e-05	0.000272	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ABCB1—ulcerative colitis	5.46e-05	0.000272	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ABCB1—ulcerative colitis	5.46e-05	0.000272	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ABCB1—ulcerative colitis	5.46e-05	0.000272	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—NFKB1—ulcerative colitis	5.45e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—TLR4—ulcerative colitis	5.45e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—HLA-DRB1—ulcerative colitis	5.44e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB9—Cell Cycle—TP53—ulcerative colitis	5.44e-05	0.000271	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—JAK2—ulcerative colitis	5.42e-05	0.00027	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—JAK2—ulcerative colitis	5.39e-05	0.000269	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ABCB1—ulcerative colitis	5.38e-05	0.000268	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IFNG—ulcerative colitis	5.32e-05	0.000265	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ICAM1—ulcerative colitis	5.3e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ICAM1—ulcerative colitis	5.3e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ICAM1—ulcerative colitis	5.3e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IFNG—ulcerative colitis	5.29e-05	0.000264	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—RELA—ulcerative colitis	5.25e-05	0.000261	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—RELA—ulcerative colitis	5.22e-05	0.00026	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ICAM1—ulcerative colitis	5.22e-05	0.00026	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD4—ulcerative colitis	5.14e-05	0.000256	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD4—ulcerative colitis	5.11e-05	0.000255	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ADCY5—ulcerative colitis	5.09e-05	0.000254	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ADCY5—ulcerative colitis	5.09e-05	0.000254	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ADCY5—ulcerative colitis	5.09e-05	0.000254	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ADCY5—ulcerative colitis	5.02e-05	0.00025	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ADRB2—ulcerative colitis	5.02e-05	0.00025	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ADRB2—ulcerative colitis	5.02e-05	0.00025	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ADRB2—ulcerative colitis	5.02e-05	0.00025	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PPARG—ulcerative colitis	5.01e-05	0.00025	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—JAK2—ulcerative colitis	5e-05	0.000249	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PPARG—ulcerative colitis	4.99e-05	0.000248	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—JAK2—ulcerative colitis	4.98e-05	0.000248	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ADRB2—ulcerative colitis	4.95e-05	0.000246	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—PPARG—ulcerative colitis	4.89e-05	0.000243	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—PPARG—ulcerative colitis	4.89e-05	0.000243	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—PPARG—ulcerative colitis	4.89e-05	0.000243	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—PPARG—ulcerative colitis	4.82e-05	0.00024	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—DLD—ulcerative colitis	4.75e-05	0.000236	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL1B—ulcerative colitis	4.74e-05	0.000236	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—CD4—ulcerative colitis	4.74e-05	0.000236	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—ulcerative colitis	4.73e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL2—ulcerative colitis	4.73e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL1B—ulcerative colitis	4.72e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—CD4—ulcerative colitis	4.72e-05	0.000235	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PTGS2—ulcerative colitis	4.71e-05	0.000234	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL2—ulcerative colitis	4.7e-05	0.000234	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PTGS2—ulcerative colitis	4.69e-05	0.000233	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CDH1—ulcerative colitis	4.69e-05	0.000233	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CDH1—ulcerative colitis	4.69e-05	0.000233	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CDH1—ulcerative colitis	4.69e-05	0.000233	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CDH1—ulcerative colitis	4.62e-05	0.00023	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—ALB—ulcerative colitis	4.51e-05	0.000224	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—ALB—ulcerative colitis	4.49e-05	0.000223	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—NFKB1—ulcerative colitis	4.43e-05	0.00022	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—NFKB1—ulcerative colitis	4.41e-05	0.000219	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ADCY5—ulcerative colitis	4.26e-05	0.000212	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ADCY5—ulcerative colitis	4.26e-05	0.000212	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ADCY5—ulcerative colitis	4.26e-05	0.000212	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ADCY5—ulcerative colitis	4.2e-05	0.000209	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—TP53—ulcerative colitis	4.14e-05	0.000206	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—TP53—ulcerative colitis	4.14e-05	0.000206	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—TP53—ulcerative colitis	4.14e-05	0.000206	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—JAK2—ulcerative colitis	4.11e-05	0.000204	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—JAK2—ulcerative colitis	4.11e-05	0.000204	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—JAK2—ulcerative colitis	4.11e-05	0.000204	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—ulcerative colitis	4.1e-05	0.000204	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—TP53—ulcerative colitis	4.08e-05	0.000203	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—JAK2—ulcerative colitis	4.05e-05	0.000202	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IFNG—ulcerative colitis	4.03e-05	0.000201	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IFNG—ulcerative colitis	4.03e-05	0.000201	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IFNG—ulcerative colitis	4.03e-05	0.000201	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—RELA—ulcerative colitis	3.98e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—RELA—ulcerative colitis	3.98e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—STAT3—ulcerative colitis	3.98e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—RELA—ulcerative colitis	3.98e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IFNG—ulcerative colitis	3.97e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—STAT3—ulcerative colitis	3.96e-05	0.000197	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—PTGS2—ulcerative colitis	3.94e-05	0.000196	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—PTGS2—ulcerative colitis	3.92e-05	0.000195	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—RELA—ulcerative colitis	3.92e-05	0.000195	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD4—ulcerative colitis	3.89e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD4—ulcerative colitis	3.89e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD4—ulcerative colitis	3.89e-05	0.000194	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD4—ulcerative colitis	3.84e-05	0.000191	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PPARG—ulcerative colitis	3.8e-05	0.000189	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PPARG—ulcerative colitis	3.8e-05	0.000189	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PPARG—ulcerative colitis	3.8e-05	0.000189	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—JAK2—ulcerative colitis	3.79e-05	0.000189	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—JAK2—ulcerative colitis	3.79e-05	0.000189	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—JAK2—ulcerative colitis	3.79e-05	0.000189	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PPARG—ulcerative colitis	3.75e-05	0.000186	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—JAK2—ulcerative colitis	3.74e-05	0.000186	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—STAT3—ulcerative colitis	3.67e-05	0.000183	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—STAT3—ulcerative colitis	3.66e-05	0.000182	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL1B—ulcerative colitis	3.6e-05	0.000179	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL1B—ulcerative colitis	3.6e-05	0.000179	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL1B—ulcerative colitis	3.6e-05	0.000179	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—CD4—ulcerative colitis	3.59e-05	0.000179	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—CD4—ulcerative colitis	3.59e-05	0.000179	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—CD4—ulcerative colitis	3.59e-05	0.000179	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL2—ulcerative colitis	3.58e-05	0.000178	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL2—ulcerative colitis	3.58e-05	0.000178	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL2—ulcerative colitis	3.58e-05	0.000178	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PTGS2—ulcerative colitis	3.57e-05	0.000178	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PTGS2—ulcerative colitis	3.57e-05	0.000178	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PTGS2—ulcerative colitis	3.57e-05	0.000178	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL1B—ulcerative colitis	3.55e-05	0.000177	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—CD4—ulcerative colitis	3.54e-05	0.000176	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL2—ulcerative colitis	3.53e-05	0.000176	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PTGS2—ulcerative colitis	3.52e-05	0.000175	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—JAK2—ulcerative colitis	3.5e-05	0.000174	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—JAK2—ulcerative colitis	3.49e-05	0.000174	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ulcerative colitis	3.42e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—ALB—ulcerative colitis	3.42e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—ALB—ulcerative colitis	3.42e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—ALB—ulcerative colitis	3.42e-05	0.00017	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—TGFB1—ulcerative colitis	3.4e-05	0.000169	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—RELA—ulcerative colitis	3.39e-05	0.000169	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—TGFB1—ulcerative colitis	3.39e-05	0.000169	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—RELA—ulcerative colitis	3.38e-05	0.000168	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—ALB—ulcerative colitis	3.37e-05	0.000168	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—NFKB1—ulcerative colitis	3.35e-05	0.000167	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—NFKB1—ulcerative colitis	3.35e-05	0.000167	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—NFKB1—ulcerative colitis	3.35e-05	0.000167	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—NFKB1—ulcerative colitis	3.31e-05	0.000165	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ADCY5—ulcerative colitis	3.2e-05	0.000159	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL8—ulcerative colitis	3.2e-05	0.000159	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—ulcerative colitis	3.19e-05	0.000159	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL8—ulcerative colitis	3.18e-05	0.000158	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL2—ulcerative colitis	3.06e-05	0.000152	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL2—ulcerative colitis	3.04e-05	0.000151	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—STAT3—ulcerative colitis	3.01e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—STAT3—ulcerative colitis	3.01e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—STAT3—ulcerative colitis	3.01e-05	0.00015	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—PTGS2—ulcerative colitis	2.99e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—PTGS2—ulcerative colitis	2.99e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—PTGS2—ulcerative colitis	2.99e-05	0.000149	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—STAT3—ulcerative colitis	2.97e-05	0.000148	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—PTGS2—ulcerative colitis	2.95e-05	0.000147	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MMP9—ulcerative colitis	2.89e-05	0.000144	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MMP9—ulcerative colitis	2.88e-05	0.000143	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—NFKB1—ulcerative colitis	2.86e-05	0.000142	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—NFKB1—ulcerative colitis	2.85e-05	0.000142	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ulcerative colitis	2.81e-05	0.00014	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—STAT3—ulcerative colitis	2.78e-05	0.000139	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—STAT3—ulcerative colitis	2.78e-05	0.000139	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—STAT3—ulcerative colitis	2.78e-05	0.000139	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—IL6—ulcerative colitis	2.78e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—IL6—ulcerative colitis	2.77e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—STAT3—ulcerative colitis	2.74e-05	0.000137	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—JAK2—ulcerative colitis	2.66e-05	0.000132	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—JAK2—ulcerative colitis	2.66e-05	0.000132	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—JAK2—ulcerative colitis	2.66e-05	0.000132	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—JAK2—ulcerative colitis	2.62e-05	0.00013	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—TGFB1—ulcerative colitis	2.58e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—TGFB1—ulcerative colitis	2.58e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—TGFB1—ulcerative colitis	2.58e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RELA—ulcerative colitis	2.57e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RELA—ulcerative colitis	2.57e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RELA—ulcerative colitis	2.57e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—STAT3—ulcerative colitis	2.57e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—IL6—ulcerative colitis	2.57e-05	0.000128	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—STAT3—ulcerative colitis	2.56e-05	0.000127	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—IL6—ulcerative colitis	2.55e-05	0.000127	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—TGFB1—ulcerative colitis	2.54e-05	0.000127	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RELA—ulcerative colitis	2.54e-05	0.000126	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL8—ulcerative colitis	2.42e-05	0.000121	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL8—ulcerative colitis	2.42e-05	0.000121	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL8—ulcerative colitis	2.42e-05	0.000121	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL8—ulcerative colitis	2.39e-05	0.000119	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TGFB1—ulcerative colitis	2.38e-05	0.000119	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TGFB1—ulcerative colitis	2.37e-05	0.000118	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL2—ulcerative colitis	2.32e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL2—ulcerative colitis	2.32e-05	0.000115	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL2—ulcerative colitis	2.32e-05	0.000115	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS1—ulcerative colitis	2.29e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL2—ulcerative colitis	2.28e-05	0.000114	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MMP9—ulcerative colitis	2.19e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MMP9—ulcerative colitis	2.19e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MMP9—ulcerative colitis	2.19e-05	0.000109	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—NFKB1—ulcerative colitis	2.17e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—NFKB1—ulcerative colitis	2.17e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—NFKB1—ulcerative colitis	2.17e-05	0.000108	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MMP9—ulcerative colitis	2.16e-05	0.000108	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ALB—ulcerative colitis	2.15e-05	0.000107	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—NFKB1—ulcerative colitis	2.14e-05	0.000106	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—IL6—ulcerative colitis	2.11e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—IL6—ulcerative colitis	2.11e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—IL6—ulcerative colitis	2.11e-05	0.000105	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—IL6—ulcerative colitis	2.08e-05	0.000103	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CALM3—ulcerative colitis	2.07e-05	0.000103	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—TP53—ulcerative colitis	1.96e-05	9.77e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—TP53—ulcerative colitis	1.95e-05	9.72e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—STAT3—ulcerative colitis	1.95e-05	9.7e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—STAT3—ulcerative colitis	1.95e-05	9.7e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—STAT3—ulcerative colitis	1.95e-05	9.7e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—IL6—ulcerative colitis	1.94e-05	9.68e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—IL6—ulcerative colitis	1.94e-05	9.68e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—IL6—ulcerative colitis	1.94e-05	9.68e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—STAT3—ulcerative colitis	1.92e-05	9.57e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—IL6—ulcerative colitis	1.92e-05	9.54e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TGFB1—ulcerative colitis	1.81e-05	9e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TGFB1—ulcerative colitis	1.81e-05	9e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TGFB1—ulcerative colitis	1.81e-05	9e-05	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—IL6—ulcerative colitis	1.8e-05	8.94e-05	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—IL6—ulcerative colitis	1.79e-05	8.9e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TGFB1—ulcerative colitis	1.78e-05	8.87e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ADCY5—ulcerative colitis	1.5e-05	7.46e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—TP53—ulcerative colitis	1.49e-05	7.41e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—TP53—ulcerative colitis	1.49e-05	7.41e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—TP53—ulcerative colitis	1.49e-05	7.41e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—TP53—ulcerative colitis	1.47e-05	7.3e-05	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—IL6—ulcerative colitis	1.36e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—IL6—ulcerative colitis	1.36e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—IL6—ulcerative colitis	1.36e-05	6.78e-05	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—IL6—ulcerative colitis	1.34e-05	6.68e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PPARG—ulcerative colitis	1.12e-05	5.56e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ALB—ulcerative colitis	1e-05	5e-05	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—PTGS2—ulcerative colitis	8.79e-06	4.38e-05	CbGpPWpGaD
